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Summary: The complete sequencing of genomes and the development of in
silico methods for identification of genes encoding selenocysteine (Sec)containing proteins have greatly contributed to shape our view on the
evolution of selenium utilization in nature. Current evidence is consistent
with the idea that Sec decoding is a late addition to the genetic code and it
evolved once, before the separation of archaeal, bacterial and eukaryal
domains. Many organisms have lost the Sec decoding trait, but recent
evidence has shown that the loss is not irreversible. The distribution of
organisms that use UGA as a Sec codon suggests that Sec decoding evolved
as a result of speciation, differential gene loss and horizontal gene transfer.
Selenium is also used in the synthesis 2-selenouridine, a modified base of
unknown function located in the wobble position of certain tRNAs. It has
been recently demonstrated that selenouridine and Sec-decoding traits can
evolve independently of each other, but both require selenophosphate
synthetase. This ATP-dependent enzyme emerged as a key feature of
selenium utilization that allows separation of selenium from the pathways of
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sulfur utilization and non-specific use of selenium. Some animals, including
mammals, evolved two selenophosphate synthetases, highlighting an
unknown complexity of selenium utilization in nature.

Introduction
Co-translational incorporation of selenocysteine (Sec) into nascent
polypeptides is neither canonical nor universal. A Sec-decoding apparatus is
needed to reprogram specific UGA codons [I-31. The Sec-decoding
apparatus and selenoprotein genes are present in the three domains of life;
yet, many taxa lack them. In Sec decoding species, the selenoproteome
consists of a restricted number of proteins [4,5]. All these observations have
raised important questions regarding the evolution of Sec utilization in
nature. For example, how and when did the translation machinery to decode
Sec evolve? If it evolved once, has it been perpetuated solely by vertical
descent? Has the UGA codon evolved from nonsense to sense or vice versa?
Have extant selenoproteins evolved from Cys-containing proteins or vice
versa? What are the selective forces that result in maintenance, loss and
acquisition of the Sec-decoding trait and selenoproteins? In a broader
scenario, studies on the evolution of Sec invite more in-depth questions
regarding the evolution of the genetic code and the translation machinery.
Recent work allowed some of these questions to be answered providing a
provisional evolutionary scenario [S-71. At the same time, some unknowns
remain. In this chapter we review the current knowledge regarding Sec and
selenium utilization in nature, their evolution, and highlight a key role of
selenophosphate synthetase in these processes.
Sec decoding: common origin before the division of the three domains?
Current evidence strongly suggests that the Sec decoding trait evolved once,
before the division of bacterial, archaeal and eukaryal domains. For example,
there are fundamental similarities in the three domains: i) Sec is decoded by
(also
~ known
~
as selC) and a dedicated elongation
UGA-matching ~ R N A
factor (EFsec, also known as selB); ii) the translational reprogramming is
fulfilled by the SECIS element present in selenoprotein rnRNAs; and iii) Sec
synthesis occurs on a tRNA scaffold as reviewed in [2,3,8,9]. A common
origin is further supported by the recent phylogenetic analysis of the genes
involved in Sec decoding [7], which indicates that the trait is monophyletic
in the bacterial domain and that eukaryal and archaeal Sec-decoding genes
have a common ancestor. These observations suggest that the most
parsimonious and likely evolutionary scenario for the trait is a common
origin between the three domains, and not independent origins. The greater
similarity between archaeal and eukaryal domains may reflect the fact that
the transcription and translation machinery in archaea and eukarya is thought
to be of common origin. Further studies should be carried out to identifl and
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date the time of divergence of the different genes involved in Sec decoding
and compare these patterns with divergence of the three domains. Syvanen
[lo] has proposed that the unity of the genetic code is the product of an
evolutionary process that has continued since the diversification of the major
domains and specifically suggested that the last common ancestor (which
defines the origin of the three domains) did not use arginine and tryptophan.
In this alternative scenario, horizontal gene transfer (HGT) would have
played a critical role in homogenization of the code. If this proposition is
correct, it is then possible that Sec might not have been the 2lStamino acid
added to the genetic code.
Despite the remarkable similarities, differences do exist in the Secdecoding traits in the three domains of life, including an increased
complexity of the pathway in eukaryotes 111-141. It has been argued that the
differences between bacterial and eukaryal Sec incorporation are due to a
refinement of the mechanism to provide an increased efficiency in Sec
incorporation [15]. It is also likely that some changes favored a greater
flexibility in reprogramming. Indeed, the location of the SECIS element
within the untranslated region in archaea and eukarya released the
constraints imposed by the location of SECIS immediately downstream of
U G A ~ within
'
the coding region of bacterial messages.

The Sec decoding trait can be lost, but not irreversibly
Recently, the distribution of the Sec-decoding trait was analyzed
systematically by searching complete genomes for the presence of genes
involved in Sec decoding and selenoprotein(s) and using this information to
construct a provisional "Sec decoding map" within the "tree of life" 171. This
study revealed that the trait is present in most phyla, but absent in many
species, and provided clues regarding the evolution of Sec. Then, the
phylogenies of the Sec-decoding genes were inferred and compared to
organisrnal phylogenies. This approach explained the spread and "holed"
pattern of Sec-decoding species within the tree of life as the result of
speciation, differential gene loss and horizontal gene transfer (HGT). It also
revealed that the loss of the trait is a phenomenon that takes place within
clades at different evolutionary levels, implying that the loss occurred not
only at rather basal evolutionary levels (e.g., phylum and class), but also in
recent lineages (e.g., genus and species). A stunning example of the latter is
the case of the C092 and mediaevalis strains of Yersinia pestis that have lost
the ability to decode Sec (possess functional ~RNA- and Sec synthase but
an EFsec pseudogene) while the KIM strain retains this ability
(unpublished). Yet, the main disclosure of the study was that it clearly
demonstrated that the loss of the trait was not irreversible, indicating that the
genetic code can be "rewired" by HGT, a possibility previously thought as
highly unlikely [16]. This phenomenon was patently observed in the case of
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Photobacterium profundum, which did not acquire its extant trait and the
selenoproteins involved in the glycine reductase complex by vertical descent
from a proteobacterial ancestor, but rather from a different lineage.
Incongruences possibly attributable to HGT, between gene and species trees
were also observed in the case of Pseudomomas spp. (y-proteobacteria),
Sinorhizobium meliloti (a-proteobacterium) and Burkholderia spp (Pproteobacteria). In these species, the only selenoprotein is the a-subunit of
formate dehydrogenase. In this regard, it should be noted that Pseudomonas
spp, S. meliloti and Burkholderia pseudomallei are soil colonizing bacteria
[17,18]; whereas S. meliloti and Pseudomonas spp. even compete for
nodulation on some plants. It was speculated that a putative vector for
acquisition of the trait may exist, on the basis of the observation that S.
meliloti contains the genetic information for selenoproteins and the Secdecoding trait within a megaplasmid (pSymA) with a high number of
transposons [I 51.

Selenophosphate synthetase: an essential enzyme for selenium
utilization
Selenophosphate synthetase (SPS) is an essential enzyme for selenium
utilization: it catalyzes the synthesis of monoselenophosphate [19], a
reduced and reactive form of selenium, which provides the selenium atom
for synthesis of Sec and 2-selenouridine, another biologically relevant form
of selenium in nature (see below and [20]). There appears to be two groups
of SPS enzymes. One group contains Sec or Cys at the active site and the
corresponding E. coli enzyme can catalyze, in vitro, the synthesis of
selenophosphate from selenide and ATP [21] as follows: ATP + HSe' + H20
H2SePOi + AMP + Pi . It should be emphasized that the Km value for
selenide is 20 pM, a concentration that would be noxious for the cell in vivo,
suggesting that selenide would not be the physiological selenium donor for
SPS2/SelD. The other group (designated SPSl) is present exclusively in
some eukaryotic organisms that also possess SPS2 (e.g., mammals); SPSl
neither contains Sec or Cys at the predicted active site position nor appears
to catalyze the in vitro reaction depicted above [22]. In vivo, human SPS2
complemented an E. coli selD mutant strain when the medium was
supplemented with selenite or Sec, restoring the activity of the selenoprotein
formate dehydrogenase to E. coli wild type levels. In contrast,
complementation with SPSl was ineffective when selenite was used as a
selenium supply, although it improved when Sec was used in the medium
[22]. These results led Tamura et a1 [22] to propose that human SPS2
functions in the pathway of de novo synthesis of selenophosphate from
selenite, after reduction of the latter, presumably, by intracellular thiols; the
Sec residue of SPS2 active site would bind this reduced selenium to form an
enzyme substrate complex. Alternatively, for SPSl catalysis, mammalian
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cells would supply an atom of Se derived fiom a Sec salvage pathway that
may recycle Sec derived from selenoproteins or from the promiscuous
incorporation of selenium instead of sulfur in the Cys metabolic pathway.
Sec P-lyases, enzymes that catalyze the conversion of Sec to Ala and a
selenium transfer form (Se*, since the redox state of Se has not been
determined), and NifS and NifS-like proteins (enzymes that provide a sulfur
atom to iron-sulfur clusters by catalyzing Cys desulfuration, and also convert
Sec to Ala and Se*) are candidate enzymes to participate in selenium
mobilization fiom Sec [23,24], and have been proposed as key players for
the Sec-salvage pathway.
It is relevant to emphasize that the bacterial NifS-like proteins CsdB, CSD,
and IscS also have an important role in selenium mobilization from Sec and
selenophosphate synthesis. Indeed, Sec and bacterial NifS-like proteins can
effectively replace the high level of free selenide in the in vitro SPS assay
[25,26]. Furthermore, the E. coli SPS (C17S) mutant, which is inactive in the
standard in vitro assay with selenide as substrate, was found to be active in
the presence of Sec and NifS proteins, suggesting a selenium delivery
function for these proteins [26]. Evidence that selenium is mobilized in vivo
from free Sec has also been obtained by Lacourciere [27]: growth of E. coli
in the presence 0.1 pM 7 5 ~~e0:e
and increasing amounts of Sec resulted in
a concomitant decrease in 7%e incorporation in formate dehydrogenase and
bulk tRNA. This led Lacourciere to propose that NifS-like proteins are
components of a selenium delivery system for the biosynthesis of
selenophosphate.
Recently, other potential selenium-binding and delivery proteins for SPS
have been characterized. Human 3-mercaptopyruvate sulfur transferase
(MST) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), bound
selenium supplied as selenodiglutathione formed from s~o:- and
glutathione; the bound selenium was readily released from MST and
GAPDH and available as a substrate for bacterial SPS [28]. Thus, in vitro,
these selenium-binding proteins and a low level of selenodigultathione
(formed from selenite and glutathione) could effectively replace the high
concentrations of selenide used in SPS assays.
Despite this considerable progress, the metabolic pathway(s) of selenium
assimilation and the physiological system that donates selenium to SPS
remain to be completely characterized and represents one of the challenges
ahead in the selenium field.

Selenophosphate synthetase: one enzyme, two selenium utilization traits
2-Selenouridine is the second major biological form of Se in nature [29]. It is
a modified base so far identified exclusively in the wobble position of the
' " ~ R N A ~in" some bacteria [30]. 2anticodon of tRNALys,~ R N A ~and
Selenouridine is synthesized by the protein designated YbbB from
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thiouridine tRNA and selenophosphate (the latter as the selenium donor).
Although it was originally thought that organisms able to synthesize 2selenouridine were the same as those able to decode Sec, it has recently been
shown that the set of organisms that synthesize 2-selenouridine overlaps
with, yet is distinct from, the set of organisms able to decode Sec (Figure 1).

L

o n l y Sec -\
incorporatio-

SPS

n=l

\

Figure 1. Sec-decoding and selenouridine (SeU) synthesis traits both require selenophosphate
synthetase (SPS). However, the set of species that decode Sec overlaps with, but is different
from, the set of species that synthesize SeU. The representation excludes species of the
eukaryal domain. Note that there is one species possessing SPS, but neither trait (see text). n=
numbers of completed prokaryotic genomes. (Total number of complete genomes analyzed
was 153.)

Indeed, SPS is required for both Sec and selenouridine synthesis. This study
allowed us to define SPS as the gene signature of selenium utilization, YbbB
as the gene signature for 2-selenouridine synthesis and EFsec and ~RNA"' as
the gene signature of the Sec-decoding trait. Thus, the likely evolutionary
scenario is that SPS is required for both traits, but Sec-decoding and 2selenouridine synthesis traits can evolve independently of each other.
Analyses of genomic organization of Se utilization genes in the bacterial
domain revealed that SPS is more often arranged in an operon with ybbB
than with EFsec (selB) and Sec synthase (selA). HGT events were also
identified for the selenouridine synthesis trait; thus, the pattern of species
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distribution for both Se traits is the result of speciation, differential gene loss
and HGT.
An interesting parallel that might be sketched for both traits is the
restricted use of selenium: it is certainly peculiar that the Sec decoding
apparatus has been maintained in some species for insertion of a single
amino acid into a
single protein; equally unusual is the finding that 2-selenouridine is used in
only three bases in the entire transcriptomes of bacteria possessing ybbB.
A1though several functions have been postulated for selenouridine, its
function is not known. Based on the facts that 2-selenouridine is found
exclusively at the wobble position of codons ending in a purine, and that
these codons pose a problem for the translation machinery, it has been
postulated that 2-selenouridine would have been an adjustment of the
decoding apparatus to increase translational fidelity [7]. Whether this base
modification occurs outside the bacterial domain is not known; a low
identity homolog to bacterial ybbB is present in Methanococcus jannaschii
and Methanopyrus kandleri [7,30].
Finally, the presence of a SPS homolog with high identity in Enterococcus
faecalis, a species that neither decodes Sec nor possesses ybbB is interesting.
Furthermore, a Sec lyase homolog and a protein involved in sulfur reduction
flank this gene in the genome. This observation suggests that there may be
an additional Se utilization trait that occurs in E. faecalis and perhaps other
organisms (unpublished).

Looking at the phenotype: evolution of selenoproteins is a highly
dynamic process
Evolution of selenoproteins is a highly dynamic process linked to the
evolution of the Sec decoding trait itself. From the mechanistic point of
view, this process involves: i) evolution of selenoproteins from Cyscontaining homologs concomitant with the acquisition of SECIS elements
[5], ii) evolution of Cys-containing proteins from selenoproteins (fossil
SECIS elements have been well documented even in Sec decoding species)
[4,31], iii) gene duplication [32,33], and iv) conceivably "invention" of
entirely new selenoprotein families for which no Cys homologs have been
detected (possibly the glycine reductase component, grdA, in bacteria [5,15],
and SelJ in eukarya [5,34]). This highly dynamic process is at least in part
due to the following processes: i) Sec and Cys can be replaced by each other
concomitant with appropriate adjustments in the protein context [35] and/or
protein concentration, and ii) the SECIS element appears to evolve easily,
especially in archaea and eukarya, in which the 3'-UTR location of this
structure is not constrained by the coding region.
Yet, the evolutionary forces that shape Sec utilization, in particular the
delicate balance between processes that maintain, acquire or lose this trait

46

Selenium: Its molecular biology and role in human health

are not clear. It has been previously postulated that the selective advantage
provided by selenoenzymes over Cys-homologs (due to the better
nucleophilicity and lower pKa of SeH in Sec over SH in Cys), might become
a disadvantage if selenium supply becomes limiting [7,15,361. In these
situations, enzymes containing Sec as catalytic residues could have evolved
into Cys-containing proteins, or alternatively, both Sec-containing and Cyscontaining forms could have been maintained allowing organisms to use Se
in a facultative manner [36]. An illustrative example of a Se facultative
organism is Methanococcus maripaludis, which represses the synthesis of
the Cys homologs when grown in a medium that contains adequate amounts
of Se, but this repression is not observed in a mutant with disrupted selB
[36]. Nevertheless, the occurrence of organisms carrying only one of the
selenium utilization traits indicates that Se availability might not be the sole
factor involved in the loss of either trait.
It is also of interest that selenoproteomes, while differing in size in
composition between various organisms, always represent a very small
subset of the total protein complement. One may consider Sec as a twoedged weapon - the advantage of having a highly reactive selenol group
might become a disadvantage if used indiscriminately to replace Cys. This
may restrict the pervasive use of Sec in the environments where Se supply
may be adequate or excessive [7]. Another conspicuous feature of Sec
utilization in nature is its idiosyncratic use by different taxa: different sets of
selenoproteins have evolved in different lineages [6,34,371. This finding
indicates adaptations in the use of Sec, presumably to fblfill particular needs.
It has been suggested that both lineage-specific expansion (presumably of
recent origin), and the presence of core selenoproteins (ancient origin)
appear to contribute to extant selenoproteomes [S].
Analyses of prokaryotic selenoproteomes revealed that formate
dehydrogenase is present in most Sec decoding organisms [$I, suggesting
that under anaerobic respiration Sec-containing formate dehydrogenase
confers a specific advantage [7]. Indeed, most of selenoprotein formate
dehydrogenase-containing species are obligatory anaerobes or facultative
aerobes; the sole exception appears to be S. melilloti, a symbiotic nitrogenfixing obligatory aerobe that lives in the oxygen-limited environment of the
nodule. On the other hand, glycine reductases, present in T. denticola, P.
profundum, T. tengcongemis and several species of the genus Clostridium
might have conferred a selective advantage allowing certain anaerobic
bacteria to conserve energy via a soluble substrate level phosphorylation
system [38].
Synthesis of S ~ C - ~ R NaAnon-canonical
~~:
mechanism
A conspicuous feature of Sec synthesis is that it occurs on its tRNA, from
s~~-~RNA&',which is then converted into S~C-~RNA*' using
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monoselenophosphate as the selenium donor [39,40]. This latter reaction is
catalyzed by Sec synthase (SelA) in the bacterial domain. The equivalent
enzyme(s) in archaea and eukarya is (are) not known, although the
mechanism is thought to involve a S ~ ~ - ~ R N A ' intermediate
~'
(Sep=phosphoserine)
.

w]

Table 1. Non-cognate charging of amino acids into tRNAs

Asn

Asp, Glu

aspRS gluRS

archaea
bacteria

CYS

S ~ P

sepRS

archaea

fMet

Met

metRS

Gln

Glu, Asp

gluRS aspRS

bacteria, organelles
archaea
bacteria

PY1

LYS

IysRSl+lysRS2

archaea

Sec

Ser

serRS

archaea
bacteria
eukarya

Nature has evolved two different mechanisms for synthesis of aminoacyltRNAs: i) the canonical one (i.e., a specific amino acyl tRNA synthetase
recognizes an amino acid and its cognate tRNA), and ii) the non-canonical
mechanism wherein the tRNA is loaded first with a "non-cognate" amino
acid that is then modified to the amino acid to be incorporated into protein.
Although the amino acid biosynthesis on a tRNA scaffold is not unique to
Sec (Table 1, after [42] and [43]), it is interesting to point out that Sec is the
sole example in which the second mechanism appears to occur in the three
domains of life, and might be the predominant or even exclusive
biosynthetic mechanism. It is also important to note that Sec synthesis
appears to resemble Cys synthesis on tRNA in two aspects: i) in archaea and
~ ~converted
'
into S ~ ~ - ~ R N whereas
A ~ ~ ' , Sep is the
eukarya, s e r - t ~ is~first
intermediate in Cys synthesis on tRNA in some archaea [44], and ii)
synthesis of Cys on tRNA is the sole mechanism by which Cys is
synthesized in a subset of archaea that use this strategy. It has been
speculated that SepCysS (the enzyme that charges Sep directly to ~ R N A ' ~ )
provided a means by which both Cys and Sec may have been originally
added to the genetic code [MI. More generally, it could be speculated that in
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situ synthesis of an amino acid provides a strategy by which the amino acid
repertoire (and the genetic code) could have been, and conceivably can be
expanded.

Lessons from the genetic code
Nearly four decades ago the genetic code was deciphered [45]. Yet, the
signals involved in translation of information are neither universal nor
completely known, and several mechanisms of reprogramming have been
documented [46]. Sec decoding provides clues to how, with very few genes,
a codon can be reprogrammed in specific messages, increasing the amino
acid repertoire. In addition, it illustrates how flexible and dynamic is the
evolution of the genetic code: the ability to decode Sec can be lost, but later
reacquired by HGT of a handful of genes. The case of Sec is also interesting
in that it is a "non-standard" amino acid that is co-translationally
incorporated, but has not been fixed as the only (or major) function of UGA
in the genetic code. In turn, this raises the question of why Sec has not been
"hardwired" (i.e., reassigned a codon), and what are the differences between
increasing the amino acid repertoire post-translationally or cotranslationally.
Stop codons have repeatedly evolved particular meanings (Trp, Cys, Sec,
Pyl) either by codon reassignment or by reprogramming, suggesting that a
change of meaning could be less deleterious for a nonsense codon. In
particular, whether the UGA codon originally specified Sec or stop has been
a matter of debate. It was speculated [16] that UGA evolved Erom sense to
nonsense, and postulated a possible scenario where Sec was one of the
earliest amino acids in evolutionary history. And once oxygen evolved in the
atmosphere, the susceptibility to oxidation could have counterselected Sec
resulting in the stop function of UGA and maintaining the Sec function by
means of SECIS element and EF-sec. On the other hand, it was also
proposed [47] that UGA evolved fiom nonsense to sense, and that Sec was
added to the already fixed code. Although the question of the ancestral
meaning of UGA is difficult to solve, the very need of reprogramming
specific messages suggests that the Sec insertion has evolved on top of an
existing translational machinery to acquire a new meaning for an already
assigned codon. In other words, "loose" programming (for specific
messages) must have been a novelty added to the "hardwired" code (i.e.,
universal, for all messages).
Further clues to the idiosyncrasies of the genetic code and its dynamic
evolution have arisen fiom pyrrolysine (Pyl), a recently discovered %onstandard" amino acid [48]. The mechanism of Pyl incorporation, in
particular whether it requires recoding (and if it does, what are the signals) is
not clear [49]. Although Sec and Pyl use dissimilar decoding strategies, there
are clear parallels: Sec and Pyl are amino acids used in a small set of
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proteins and both are expansions of the amino acid repertoire by redefining
the meaning of stop codons. The diversity of mechanisms involved in
translation, together with the simple machinery needed to expand the genetic
code, opens the door to the possibility that 22 genetically encoded amino
acids may not be the final number and that additional amino acids may exist
in the genetic code.
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